23
Views
1
CrossRef citations to date
0
Altmetric
Short Communications

Mannose-binding lectin deficiency does not appear to predispose to cryptococcosis in non-immunocompromised patients

, , , &
Pages 371-375 | Received 13 Jul 2007, Published online: 09 Jul 2009

References

  • Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 2000; 31: 499–508
  • Kidd SE, Hagen F, Tscharke RL, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101: 17258–17263
  • Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532–540
  • Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001; 180: 86–99
  • Neth O, Jack DL, Dodds AW, et al. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688–693
  • Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37: 1496–1505
  • Levitz SM, Tabuni A, Treseler C. Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes. Infect Immun 1993; 61: 4891–4893
  • Chaka W, Verheul AF, Vaishnav VV, et al. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol 1997; 159: 2979–2985
  • Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002; 56: 630–641
  • Dean MM, Minchinton RM, Heatley S, Eisen DP. Mannose binding lectin acute phase activity in patients with severe infection. J Clin Immunol 2005; 25: 346–352
  • Eisen DP, Dean MM, Thomas P, et al. Low mannose-binding lectin function is associated with sepsis in adult patients. FEMS Immunol Med Microbiol 2006; 48: 274–282
  • Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358: 637–638
  • Smithson A, Munoz A, Suarez B, et al. Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to escherichia coli. Clin Vaccine Immunol 2007; 14: 256–261
  • Eisen DP, Stubbs J, Spilsbury D, et al. Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires’ disease. Clin Exp Immunol 2007; 149: 97–102
  • Perez-Castellano M, Penaranda M, Payeras A, et al. Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia. Clin Exp Immunol 2006; 145: 228–234
  • McBride MO, Fischer PB, Sumiya M, et al. Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections. Int J STD AIDS 1998; 9: 683–688
  • Huffnagle GB, McNeil LK. Dissemination of Cryptococcus neoformans to the central nervous system: role of chemokines, Th1 immunity and leukocyte recruitment. J Neurovirol 1999; 5: 76–81
  • Kawakami K, Tohyama M, Xie Q, Saito A. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 1996; 104: 208–214
  • Kawakami K, Qureshi MH, Zhang T, et al. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol 1997; 159: 5528–5534
  • Cross CE, Bancroft GJ. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun 1995; 63: 2604–2611
  • Panepinto JC, Komperda KW, Hacham M, et al. Binding of serum mannan binding lectin to a cell integrity-defective Cryptococcus neoformans ccr4Δ mutant. Infect Immun 2007; 75: 4769–4779
  • Parrella P, Seripa D, Matera MG, et al. Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection. Eur J Epidemiol 2007; 22: 159–162
  • Lillegard JB, Sim RB, Thorkildson P, Gates MA, Kozel TR. Recognition of Candida albicans by mannan-binding lectin in vitro and in vivo. J Infect Dis 2006; 193: 1589–1597
  • Kaur S, Gupta VK, Thiel S, Sarma PU, Madan T. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol 2007; 148: 382–389
  • Granell M, Urbano-Ispizua A, Suarez B, et al. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp Hematol 2006; 34: 1435–1441
  • Mullighan CG, Heatley S, Doherty K, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99: 3524–3529
  • Moller-Kristensen M, Jensenius JC, Jensen L, et al. Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods 2003; 282: 159–167

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.